AptaBio Therapeutics Inc. (KOSDAQ:293780)
4,520.00
-30.00 (-0.66%)
Jul 3, 2026, 3:30 PM KST
-44.20% (1Y)
| Market Cap | 126.98B -39.3% |
| Revenue (ttm) | 4.27B +37.5% |
| Net Income | -20.21B |
| EPS | -733.72 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 96,315 |
| Open | 4,525.00 |
| Previous Close | 4,550.00 |
| Day's Range | 4,340.00 - 4,735.00 |
| 52-Week Range | 3,870.00 - 11,960.00 |
| Beta | 0.79 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |